Join
Live feed
·
NEWSReleasevia Quantisnow
Cosmos Health Inc. logo

Cosmos Health Continues US Expansion with Q2 Launch of Cur18 - a Clinically Studied, Patented Curcumin Next-Gen Therapy Supplement Delivering 39× Higher Bioavailability and Designed to Support Joint Health

ByQuantisnow·Wall Street's wire, on your screen.
COSM· Cosmos Health Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track COSM (Cosmos Health Inc.) and more on Quantisnow.